Statement of Deviation & Variation in PDF format along with the clarification letter in respect of BSE Email.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nukleus Office Solutions Ltd confirmed there is no deviation or variation in the use of IPO proceeds for the quarter ended March 31, 2025. The company raised ₹3,170.23 Lakhs (net proceeds ₹2,869.48 Lakhs) through its IPO in March 2025. During the quarter, it utilized ₹406.01 Lakhs for new center setup, ₹5.61 Lakhs for technology platform work, and ₹300 Lakhs for general corporate purposes, while spending nothing on advertising. The Audit Committee reviewed and confirmed full compliance with the objects stated in the IPO prospectus dated February 18, 2025. The filing also includes a clarification to BSE explaining that the Statement was already submitted in XBRL format with financial results, but the separate PDF was missed. SEBI has since discontinued the requirement for a separate PDF submission from April 1, 2025.
This is a routine compliance filing confirming IPO funds are being used as promised to investors, with no misuse or diversion. No material impact expected on the stock; it is purely procedural.